Why Major Digital Health Companies Are Absent from Medicare’s Chronic Care Pilot Program
Medicare’s latest chronic care experiment excludes big digital health players, raising questions about industry access and innovation gaps. The pilot...
Medicare’s latest chronic care experiment excludes big digital health players, raising questions about industry access and innovation gaps. The pilot...
Dr. Mehmet Oz, Administrator of CMS, announced a new coalition of 29 healthcare leaders at the Axios Future of Health Summit to simplify prior authori...
The Centers for Medicare and Medicaid Services has halted new enrollments for hospice and home health agencies for six months to combat fraudulent bus...
Medicare's initial cost estimate for the Alzheimer's drug Leqembi was $3.5 billion for 2025, but new data shows this projection was significantly over...
Medicare’s spending projections for new Alzheimer’s drugs Leqembi and Kisunla have been slashed due to minimal uptake, with no significant spending ex...
Medicare will launch a pilot program in July 2026 offering GLP-1 weight loss drugs like Wegovy and Zepbound for $50 per month. The initiative, running...
The Trump administration is pushing hospitals and nursing homes to comply with new dietary guidelines or face losing millions in federal funding. The...
The KFF Health News Minute delivers weekly insights on critical health policy shifts, from Title X changes to Medicare coverage expansions. Recent epi...
Federal regulators introduced a new Medicare coverage pathway, RAPID, to accelerate reimbursement for FDA-designated breakthrough devices. The program...
Robert F. Kennedy Jr. has softened his position on certain MAHA-related policies, following challenges in implementing a Medicare pilot program for ob...
Washington state hospitals report Medicare patients now face delays two to four times longer for procedures under CMS's new WISeR program. A Senate re...
Medicare has delayed a pilot program to cover obesity drugs for seniors, reversing a key healthcare initiative from the Trump administration. This com...
The Trump administration's Medicare obesity drug pilot was abandoned after insurers declined to participate. Meanwhile, Amazon's One Medical is launch...
The Trump administration proposed a Medicare pilot program to offer discounted weight loss drugs to seniors, but insurers declined participation. As a...